focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.60
Bid: 18.60
Ask: 19.00
Change: 0.35 (1.92%)
Spread: 0.40 (2.151%)
Open: 18.60
High: 18.60
Low: 18.60
Prev. Close: 18.25
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Quarter 2023 Update

28 Apr 2023 07:00

RNS Number : 8455X
LMS Capital PLC
28 April 2023
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28 April 2023

 

 

LMS CAPITAL PLC

First Quarter 2023 Update

 

 

LMS Capital plc (the "Company"), the listed Investment Company, provides the following update covering the three months ended 31 March 2023.

 

Financial Highlights

 

· Unaudited Net Asset Value ("NAV") at 31 March 2023 was £46.1 million (57.2p per share). This compares to £46.5 million (57.7p per share) at 31 December 2022;

· Overall portfolio net gains were £0.1 million. These comprise net underlying gains of £0.5 million (including accrued interest on Dacian) offset by unrealised foreign exchange losses of £0.4 million reflecting the weakening of the US Dollar compared to sterling in Q1; and

· Cash at 31 March 2023 was £17.5 million compared to £17.9 million at 31 December 2022.

 

Unaudited Net Asset Value at 31 March 2023

 

The 31 March 2023 NAV is summarised below:

 

Unaudited

Audited

31 March

2023

31 December

 2022

£ 000s

Mature Investment Portfolio

Quoted Investments

144

160

Unquoted Investments

6,701

6,626

Funds

13,526

14,033

20,371

20,819

New Investment Portfolio

Dacian

10,280

10,145

10,280

10,145

Total Investments

30,651

30,964

Cash

17,490

17,906

Other Net Assets/Liabilities 

(1,995)

(2,329)

Net Asset Value

46,146

46,541

 

The NAV at the end of March is based on the valuation of the Company's investments as at 31 December 2022, adjusted for transactions in the three months ended 31 March 2023, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, and the latest information available from third party fund managers.

 

The £0.4 million decrease in NAV during the first quarter is comprised of the following:

· Net underlying gains of £0.5 million on the investment portfolio;

· £0.4 million of portfolio unrealised foreign exchange losses from the strengthening of sterling against the U.S. Dollar;

· £0.1 million of non-portfolio unrealised foreign exchange losses;

· £0.5 million of running costs and £0.1 million of investment related costs; and

· £0.2 million on bank interest and other income receivable.

 

Portfolio Net Underlying Gains - £0.5 million

 

Quoted Investments

 

The Company's quoted investment valuations remained flat during the first quarter.

 

Unquoted Investments

 

The Company's unquoted investments include our direct holdings in Dacian Petroleum, Medhost, Elateral and a convertible debt instrument with IDE Group Holdings. ICU Eyewear, the final asset managed by San Francisco Equity Partners was disposed of during the period resulting in a realised gain of £0.1 million.

 

Unrealised gains on the unquoted portfolio were £0.4 million during the first quarter all resulting from Medhost.

 

Dacian Petroleum had £0.3 million in investment accrued interest income during the first quarter.

 

Funds

 

The Company's fund investments include its holding in Brockton Capital Fund I, Opus Capital Venture Partners, Weber Capital Partners and five other smaller fund interests.

 

Fund unrealised net losses were £0.3 million. The principal movements were:

· Opus Capital Venture Partners - Unrealised loss of £0.8 million, driven by a reduction in the fund manager's valuation of the Fund's two principal remaining investments, primarily reflecting movements in comparable market indices;

· Brockton Capital Fund 1 - Unrealised gain of £0.3 million, reflecting the unwinding of the discount rate as the investment is valued on a discounted cash flow basis;

· Weber Capital Partners - Unrealised gain of £0.1 million due to the performance in the U.S. microcap equities held in the fund; and

· Other unrealised gains on funds of £0.1 million.

 

The carrying value of the funds is based on the latest available information from the respective fund managers, generally the 31 December 2022 fund valuation reports except for Weber Capital Partners, which is based on 31 March 2023 valuations.

 

Liquidity and Outlook

 

Portfolio realisations were £0.3 million during the period.

 

Cash balances were £17.5 million at 31 March 2023.

 

As laid out in our Annual Report, our 2023 priorities are:

· to bring to fruition the work that has been undertaken, particularly with our real estate teams, to deploy new capital from our own balance sheet in conjunction with our co-investors;

· to support the Dacian team as it enters its second year of operation with an emphasis on its workover program to increase production; and

· to continue to manage the mature asset portfolio to optimise realisation proceeds

 

 

 

For further information please contact:

LMS Capital plc

Nick Friedlos, Managing Director

0207 935 3555

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFIPMITMTATMTJ
Date   Source Headline
19th Nov 20081:00 pmRNSUpdate re discussions with LMS Capital plc
19th Nov 200811:52 amRNSLMS Capital plc ends discussions with Dmatek Ltd
14th Nov 200810:30 amRNSTransactions in own shares
12th Nov 20081:25 pmRNSTransaction in own shares
7th Oct 20087:55 amRNSResponse to Press Speculation
7th Oct 20087:00 amRNSStatement re. Press Comment
1st Oct 20084:31 pmRNSHolding(s) in Company
30th Sep 20084:23 pmRNSTransaction in own shares
30th Sep 200810:34 amRNSPublication of Interim Report 2008
29th Sep 20084:15 pmRNSTransaction in own shares
29th Sep 200811:00 amRNSHolding in Company
15th Sep 20083:02 pmRNSHolding in Company
15th Sep 20082:01 pmRNSHolding in Company
12th Sep 20089:57 amRNSHolding in Company
11th Sep 20087:00 amRNSInterim Results
9th Sep 200810:30 amRNSHolding in Company
4th Aug 200810:51 amRNSHolding(s) in Company
20th Jun 20087:00 amRNSLMS Capital invests in Pims G
13th Jun 20083:07 pmRNSTransaction in own shares
6th Jun 20082:50 pmRNSAGM Poll Results
6th Jun 20087:00 amRNSAGM Statement
19th May 20087:00 amRNSAcquisition
25th Apr 20083:00 pmRNSAnnual Report 2007
2nd Apr 20084:15 pmRNSNotification of Transactions
31st Mar 20089:01 amRNSSale of ECI Ltd & Nav Update
26th Mar 200812:57 pmRNSHolding(s) in Company
26th Mar 20087:01 amRNSFinal Results
25th Mar 20087:01 amRNSResponse to Press Speculation
20th Feb 20082:49 pmRNSNotice of Results
29th Jan 20082:26 pmRNSHolding(s) in Company
22nd Jan 20084:58 pmRNSHolding in Company
8th Jan 20087:00 amRNSInvestor Presentation release
11th Dec 200710:52 amRNSNotifiable Interest
28th Nov 20074:44 pmRNSNotification of Transaction
9th Nov 20074:54 pmRNSInterests in Shares
9th Nov 20074:33 pmRNSPurchase of Shares
24th Sep 20073:24 pmRNSTransaction in Own Shares
21st Sep 20072:17 pmRNSInterim Report 2007
18th Sep 20073:24 pmRNSDirectors' dealings
17th Sep 20077:00 amRNSInterim Results
4th Sep 20071:33 pmRNSAcquisition
3rd Sep 20077:00 amRNSAdviser Appointment
9th Aug 20072:48 pmRNSHolding(s) in Company
2nd Jul 20073:39 pmRNSHolding(s) in Company
2nd Jul 20073:16 pmRNSDirector/PDMR Shareholding
29th Jun 20074:04 pmRNSLMS Capital - Investment
10th May 20071:00 pmRNSResult of AGM
10th May 20077:01 amRNSAGM Statement
8th May 20075:00 pmRNSAnnual Information Update
17th Apr 20071:08 pmRNSDirector/PDMR S/hldg-Replace

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.